Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 14,052.00p on 16-01-2026 at 19:40:05
Change 26.00p 0.19%
Buy 14,058.00p
Sell 14,054.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 91.00 at 14,052.00p
Day's Volume: 3,712,321
Last Close: 14,052.00p
Open: 14,020.00p
ISIN: GB0009895292
Day's Range 13,972.00p - 14,154.00p
52wk Range: 9,574.00p - 14,408.00p
Market Capitalisation: £217.85b
VWAP: 14,044.54252p
Shares in Issue: 1.55b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 91 14,052.00p SI Trade
Negotiated Trade
 16:48:47 - 16-Jan-26
Buy* 37,342 14,065.267p SI Trade
Negotiated Trade
 16:47:04 - 16-Jan-26
Buy* 15,000 14,052.00p SI Trade
 16:45:23 - 16-Jan-26
Buy* 2 14,052.00p SI Trade
 16:35:07 - 16-Jan-26
Buy* 2 14,052.00p SI Trade
 16:35:07 - 16-Jan-26
Buy* 6 14,052.00p SI Trade
 16:35:07 - 16-Jan-26
Buy* 34 14,052.00p SI Trade
 16:35:07 - 16-Jan-26
Buy* 2 14,052.00p SI Trade
 16:35:07 - 16-Jan-26
Buy* 1 14,052.00p SI Trade
 16:35:07 - 16-Jan-26
Buy* 116 14,052.00p SI Trade
 16:35:07 - 16-Jan-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
16th Jan 2026 (Fri) 14,020.00 14,154.00 13,972.00 14,052.00 3,712,321
15th Jan 2026 (Thu) 14,326.00 14,408.00 13,982.00 14,026.00 2,722,021
14th Jan 2026 (Wed) 14,080.00 14,396.00 14,072.00 14,346.00 3,068,095
13th Jan 2026 (Tue) 13,978.00 14,060.00 13,804.00 14,008.00 3,158,493
12th Jan 2026 (Mon) 14,036.00 14,266.00 13,882.00 14,120.00 2,193,793
9th Jan 2026 (Fri) 14,010.00 14,330.00 13,974.00 14,216.00 1,510,712
8th Jan 2026 (Thu) 14,030.00 14,292.00 14,022.00 14,176.00 2,489,065
7th Jan 2026 (Wed) 14,050.00 14,312.00 14,038.00 14,224.00 2,010,791
6th Jan 2026 (Tue) 13,400.00 14,114.00 13,392.00 14,038.00 2,053,602
5th Jan 2026 (Mon) 13,644.00 13,644.00 13,278.00 13,384.00 1,631,479
2nd Jan 2026 (Fri) 13,722.00 13,916.00 13,592.00 13,592.00 3,980,211
1st Jan 2026 (Thu) 13,790.00 13,790.00 13,790.00 13,790.00 0
31st Dec 2025 (Wed) 13,768.00 13,844.00 13,722.00 13,790.00 393,700
30th Dec 2025 (Tue) 13,712.00 13,798.00 13,696.00 13,750.00 950,185
29th Dec 2025 (Mon) 13,736.00 13,806.00 13,680.00 13,748.00 1,490,186
26th Dec 2025 (Fri) 13,674.00 13,674.00 13,674.00 13,674.00 0
25th Dec 2025 (Thu) 13,674.00 13,674.00 13,674.00 13,674.00 0
24th Dec 2025 (Wed) 13,742.00 13,742.00 13,612.00 13,674.00 688,169
23rd Dec 2025 (Tue) 13,612.00 13,806.00 13,604.00 13,736.00 1,082,889
22nd Dec 2025 (Mon) 13,592.00 13,632.00 13,476.00 13,632.00 1,451,074
19th Dec 2025 (Fri) 13,574.00 13,714.00 13,508.00 13,672.00 10,404,455
18th Dec 2025 (Thu) 13,500.00 13,594.00 13,376.00 13,548.00 4,515,814
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
8th Jan 2026 7:00 am RNS AZN new Head of Investor Relations Joris Silon
2nd Jan 2026 3:00 pm RNS Total Voting Rights
22nd Dec 2025 11:00 am RNS Director/PDMR Shareholding
22nd Dec 2025 11:00 am RNS Director/PDMR Shareholding
22nd Dec 2025 7:30 am RNS Enhertu granted BTD for post-neoadjuvant early BC
22nd Dec 2025 7:30 am RNS Enhertu granted BTD for post-neoadjuvant early BC
22nd Dec 2025 7:00 am RNS Update on LATIFY Phase III trial of ceralasertib
22nd Dec 2025 7:00 am RNS Update on LATIFY Phase III trial of ceralasertib
19th Dec 2025 11:00 am RNS Director/PDMR Shareholding
19th Dec 2025 11:00 am RNS Director/PDMR Shareholding
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

LONDON BROKER RATINGS: BofA cuts British Land; RBC raises Gym Group

16th Jan 2026 09:48

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON MARKET CLOSE: Stocks in green as US manufacturing surprises

15th Jan 2026 17:00

(Alliance News) - Stock prices in London closed higher on Thursday, after a surprise drop in US jobless claims. Read More

Hutchmed China hails lung cancer trial results published in Lancet

14th Jan 2026 12:06

(Alliance News) - Hutchmed China Ltd on Wednesday said the results from its SACHI phase-three lung cancer trial have been published in medical journal the Lancet. Read More

LONDON MARKET MIDDAY: Miners lift FTSE 100 ahead of US PPI

14th Jan 2026 11:57

(Alliance News) - Stock prices in London were mixed at midday on Wednesday, as gains among miners lifted the FTSE 100. Read More

Polar Capital Global Healthcare Trust beats benchmark; demand "robust"

14th Jan 2026 10:10

(Alliance News) - Polar Capital Global Healthcare Trust PLC on Wednesday said demand for healthcare products remains robust as it outperformed its benchmark. Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,235.29
Change-3.65

Login to your account

Forgot Password?

Not Registered